CDKN2A and neoplasm: Recognising the limited knowledge on which role these proteins play in the immune response and resistance to tumour recurrence in p16+ and p16- HNSCC, respectively, it is reasonable to consider how the levels of immune proteins in the blood represent events in the tumour tissue and the tumour microenvironment.